137 related articles for article (PubMed ID: 22427053)
21. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
22. Simplet/Fam53b is required for Wnt signal transduction by regulating β-catenin nuclear localization.
Kizil C; Küchler B; Yan JJ; Özhan G; Moro E; Argenton F; Brand M; Weidinger G; Antos CL
Development; 2014 Sep; 141(18):3529-39. PubMed ID: 25183871
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of IL-9 receptor in diffuse large B-cell lymphoma.
Lv X; Feng L; Fang X; Jiang Y; Wang X
Int J Clin Exp Pathol; 2013; 6(5):911-6. PubMed ID: 23638223
[TBL] [Abstract][Full Text] [Related]
24. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
[TBL] [Abstract][Full Text] [Related]
26. Aberrant activation of the WNT/β-catenin signaling pathway in lupus nephritis.
Wang XD; Huang XF; Yan QR; Bao CD
PLoS One; 2014; 9(1):e84852. PubMed ID: 24465439
[TBL] [Abstract][Full Text] [Related]
27. Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways.
Mansoor A; Kamran H; Akhter A; Seno R; Torlakovic EE; Roshan TM; Shabani-Rad MT; Elyamany G; Minoo P; Stewart D
Mod Pathol; 2023 Aug; 36(8):100198. PubMed ID: 37105495
[TBL] [Abstract][Full Text] [Related]
28. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
29. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression.
Chen XY; Wang ZC; Li H; Cheng XX; Sun Y; Wang XW; Wu ML; Liu J
Hum Pathol; 2005 Dec; 36(12):1294-301. PubMed ID: 16311123
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.
Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831
[TBL] [Abstract][Full Text] [Related]
31. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
Rodig SJ; Savage KJ; LaCasce AS; Weng AP; Harris NL; Shipp MA; Hsi ED; Gascoyne RD; Kutok JL
Am J Surg Pathol; 2007 Jan; 31(1):106-12. PubMed ID: 17197926
[TBL] [Abstract][Full Text] [Related]
32. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
[TBL] [Abstract][Full Text] [Related]
33. ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma.
Wu J; He Z; Zhu Y; Jiang C; Deng Y; Wei B
Curr Cancer Drug Targets; 2021; 21(1):80-89. PubMed ID: 32933462
[TBL] [Abstract][Full Text] [Related]
34. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
35. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
36. [Activation and clinicopathologic significance of AKT/mTOR signaling pathway in diffuse large B-cell lymphoma].
Yu BH; Zhou XY; Xiao XY; Yan SY; Qin T; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):35-41. PubMed ID: 19489223
[TBL] [Abstract][Full Text] [Related]
37. β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Anand M; Lai R; Gelebart P
Haematologica; 2011 Feb; 96(2):253-61. PubMed ID: 20971814
[TBL] [Abstract][Full Text] [Related]
38. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.
Yang B; Wang S; Xie H; Wang C; Gao X; Rong Y; Liu Z; Lu Y
J Cell Physiol; 2020 Oct; 235(10):6507-6514. PubMed ID: 32052444
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.
Li L; Xu-Monette ZY; Ok CY; Tzankov A; Manyam GC; Sun R; Visco C; Zhang M; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Wang J; Parsons BM; Winter JN; Piris MA; Pham LV; Medeiros LJ; Young KH
Oncotarget; 2015 Sep; 6(27):23157-80. PubMed ID: 26324762
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
